BSE Live
Oct 01, 16:01Prev. Close
1126.00
Open Price
1126.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 01, 15:44Prev. Close
1127.70
Open Price
1123.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
Key Financial Ratios of SMS Lifesciences India (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 70.69 | 43.22 | 43.72 | 83.95 | 43.56 | |
Diluted EPS (Rs.) | 70.69 | 43.22 | 43.72 | 83.95 | 43.56 | |
Cash EPS (Rs.) | 104.61 | 77.13 | 70.75 | 110.38 | 67.42 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 652.19 | 582.90 | 542.55 | 500.16 | 417.88 | |
Book Value [InclRevalReserve]/Share (Rs.) | 652.19 | 582.90 | 542.55 | 500.16 | 417.88 | |
Dividend / Share(Rs.) | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | |
Revenue from Operations/Share (Rs.) | 1,102.67 | 992.30 | 1,042.71 | 1,143.21 | 860.83 | |
PBDIT/Share (Rs.) | 159.35 | 126.58 | 96.87 | 108.82 | 102.76 | |
PBIT/Share (Rs.) | 125.43 | 92.66 | 69.84 | 82.39 | 78.90 | |
PBT/Share (Rs.) | 99.37 | 63.22 | 60.77 | 109.08 | 64.02 | |
Net Profit/Share (Rs.) | 70.69 | 43.22 | 43.72 | 83.95 | 43.56 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 14.45 | 12.75 | 9.29 | 9.51 | 11.93 | |
PBIT Margin (%) | 11.37 | 9.33 | 6.69 | 7.20 | 9.16 | |
PBT Margin (%) | 9.01 | 6.37 | 5.82 | 9.54 | 7.43 | |
Net Profit Margin (%) | 6.41 | 4.35 | 4.19 | 7.34 | 5.05 | |
Return on Networth / Equity (%) | 10.83 | 7.41 | 8.05 | 16.78 | 10.42 | |
Return on Capital Employed (%) | 16.20 | 12.46 | 9.30 | 12.90 | 14.26 | |
Return on Assets (%) | 5.96 | 3.76 | 3.91 | 8.13 | 4.84 | |
Total Debt/Equity (X) | 0.40 | 0.50 | 0.52 | 0.40 | 0.33 | |
Asset Turnover Ratio (%) | 0.94 | 0.88 | 0.97 | 1.18 | 95.77 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 1.43 | 1.42 | 1.52 | 1.36 | 1.30 | |
Quick Ratio (X) | 0.94 | 0.81 | 0.79 | 0.68 | 0.73 | |
Inventory Turnover Ratio (X) | 2.43 | 2.08 | 2.35 | 3.09 | 4.43 | |
Dividend Payout Ratio (NP) (%) | 0.00 | 3.47 | 3.43 | 1.78 | 0.00 | |
Dividend Payout Ratio (CP) (%) | 0.00 | 1.94 | 2.12 | 1.35 | 0.00 | |
Earnings Retention Ratio (%) | 0.00 | 96.53 | 96.57 | 98.22 | 0.00 | |
Cash Earnings Retention Ratio (%) | 0.00 | 98.06 | 97.88 | 98.65 | 0.00 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 404.40 | 292.68 | 241.40 | 267.72 | 182.53 | |
EV/Net Operating Revenue (X) | 1.21 | 0.98 | 0.77 | 0.77 | 0.70 | |
EV/EBITDA (X) | 8.39 | 7.65 | 8.24 | 8.14 | 5.88 | |
MarketCap/Net Operating Revenue (X) | 0.98 | 0.68 | 0.50 | 0.61 | 0.57 | |
Retention Ratios (%) | 0.00 | 96.52 | 96.56 | 98.21 | 0.00 | |
Price/BV (X) | 1.66 | 1.16 | 0.96 | 1.39 | 1.18 | |
Price/Net Operating Revenue | 0.98 | 0.68 | 0.50 | 0.61 | 0.57 | |
Earnings Yield | 0.07 | 0.06 | 0.08 | 0.12 | 0.09 |
08.09.2025
SMS Lifescience Standalone June 2025 Net Sales at Rs 79.04 crore, down 8.7% Y-o-Y
12.06.2025
SMS Lifescience Standalone March 2025 Net Sales at Rs 85.43 crore, down 1.1% Y-o-Y
04.06.2025
SMS Lifescience Consolidated March 2025 Net Sales at Rs 89.11 crore, down 0.98% Y-o-Y
04.03.2025
SMS Lifescience Consolidated December 2024 Net Sales at Rs 84.60 crore, up 17.41% Y-o-Y
08.09.2025
SMS Lifescience Standalone June 2025 Net Sales at Rs 79.04 crore, down 8.7% Y-o-Y
12.06.2025
SMS Lifescience Standalone March 2025 Net Sales at Rs 85.43 crore, down 1.1% Y-o-Y
04.06.2025
SMS Lifescience Consolidated March 2025 Net Sales at Rs 89.11 crore, down 0.98% Y-o-Y
04.03.2025
SMS Lifescience Consolidated December 2024 Net Sales at Rs 84.60 crore, up 17.41% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017